Cosentyx (secukinumab) - Novartis
Study on Secukinumab Combined with Moisturizer in the Treatment of Psoriasis (ChiCTR) - Oct 16, 2026 - P=N/A | N=66 | Completed | Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine; Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School o 
New trial • Dermatology • Immunology • Psoriasis
https://www.chictr.org.cn/showproj.html?proj=340366
 
Oct 16, 2026
 
Prev Next